|
Advanced Hormone-Sensitive Breast Cancer Responds To Osteoporosis Drug
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco...
More... |
| All times are GMT -7. The time now is 06:56 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021